Analyzing and modeling massive transfusion strategies and the role of fibrinogen—How much is the patient actually receiving?

Documenti analoghi

• Revisiting whole blood transfusion for the massively bleeding patient: The origins of resistance to change
  di: Evan M. Bloch, et al.
  Pubblicazione: (2025)
• Expanding beyond trauma: Characterizing low titer group O whole blood (LTOWB) use in children requiring massive transfusion protocol activation
  di: Erin V. Feeney, et al.
  Pubblicazione: (2025)
• The clinical use of cryoprecipitate and fibrinogen concentrate: A scoping review
  di: Aaron S. Hess, et al.
  Pubblicazione: (2026)
• A prehospital protocol for transfusion of low‐titer O‐positive whole blood in patients with hemorrhagic shock in Los Angeles County: Modeling the risk of hemolytic disease of the fetus and newborn
  di: Kelsey Wilhelm, et al.
  Pubblicazione: (2025)
• On lower fibrinogen threshold for fibrinogen replacement in plasma exchange: Perhaps for patients with no bleeding risk, but there are more shades of gray
  di: Matej Zrimsek, et al.
  Pubblicazione: (2025)